AI Generated Image
A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda
The New York Times • • business
Key Points:
- The FDA advisory committee is set to discuss whether to allow specialized pharmacies to produce seven peptide injections previously banned due to safety concerns, a move supported by Health and Human Services Secretary Robert F. Kennedy Jr., who has promoted these unproven treatments.
- FDA scientists recommend against broader use of these peptides, citing insufficient understanding of their risks and benefits, while the peptides continue to be marketed online for various unverified health claims.
- The 19-member advisory committee includes six individuals who sell or dispense peptides, raising concerns about potential conflicts of interest, as FDA panels are typically composed of neutral outside experts.
- Critics note the committee's composition appears influenced by Kennedy, though the Department of Health and Human Services states all members underwent standard ethics reviews and those failing to meet requirements were excluded.
